Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.

Saved in:
Bibliographic Details
Title: Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
Authors: Kato S; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Li B; Ambry Genetics, Aliso Viejo, CA, USA., Adashek JJ; Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Cha SW; Ambry Genetics, Aliso Viejo, CA, USA., Bianchi-Frias D; Ambry Genetics, Aliso Viejo, CA, USA., Qian D; Ambry Genetics, Aliso Viejo, CA, USA., Kim L; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., So TW; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Mitchell M; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA., Kamei N; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Hoiness R; Ambry Genetics, Aliso Viejo, CA, USA., Hoo J; Ambry Genetics, Aliso Viejo, CA, USA., Gray PN; Ambry Genetics, Aliso Viejo, CA, USA., Iyama T; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Kashiwagi M; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan., Lu HM; Ambry Genetics, Aliso Viejo, CA, USA., Kurzrock R; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.
Source: Oncoimmunology [Oncoimmunology] 2022 Mar 29; Vol. 11 (1), pp. 2052410. Date of Electronic Publication: 2022 Mar 29 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35371621
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kato+S%22">Kato S</searchLink>; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Li+B%22">Li B</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Adashek+JJ%22">Adashek JJ</searchLink>; Department of Internal Medicine, University of South Florida, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Cha+SW%22">Cha SW</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bianchi-Frias+D%22">Bianchi-Frias D</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Qian+D%22">Qian D</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kim+L%22">Kim L</searchLink>; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22So+TW%22">So TW</searchLink>; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+M%22">Mitchell M</searchLink>; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kamei+N%22">Kamei N</searchLink>; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Hoiness+R%22">Hoiness R</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hoo+J%22">Hoo J</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gray+PN%22">Gray PN</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Iyama+T%22">Iyama T</searchLink>; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Kashiwagi+M%22">Kashiwagi M</searchLink>; Bio Advanced Technology Division, Corporate R&D Headquarters, Konica Minolta, Inc, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Lu+HM%22">Lu HM</searchLink>; Ambry Genetics, Aliso Viejo, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Center for Personalized Cancer Therapy and Division of Hematology and Oncology, Department of Medicine, UC San Diego Moores Cancer Center, La Jolla, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2022 Mar 29; Vol. 11 (1), pp. 2052410. <i>Date of Electronic Publication: </i>2022 Mar 29 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35371621
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2022.2052410
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2052410
    Titles:
      – TitleFull: Serial changes in liquid biopsy-derived variant allele frequency predict immune checkpoint inhibitor responsiveness in the pan-cancer setting.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kato S
      – PersonEntity:
          Name:
            NameFull: Li B
      – PersonEntity:
          Name:
            NameFull: Adashek JJ
      – PersonEntity:
          Name:
            NameFull: Cha SW
      – PersonEntity:
          Name:
            NameFull: Bianchi-Frias D
      – PersonEntity:
          Name:
            NameFull: Qian D
      – PersonEntity:
          Name:
            NameFull: Kim L
      – PersonEntity:
          Name:
            NameFull: So TW
      – PersonEntity:
          Name:
            NameFull: Mitchell M
      – PersonEntity:
          Name:
            NameFull: Kamei N
      – PersonEntity:
          Name:
            NameFull: Hoiness R
      – PersonEntity:
          Name:
            NameFull: Hoo J
      – PersonEntity:
          Name:
            NameFull: Gray PN
      – PersonEntity:
          Name:
            NameFull: Iyama T
      – PersonEntity:
          Name:
            NameFull: Kashiwagi M
      – PersonEntity:
          Name:
            NameFull: Lu HM
      – PersonEntity:
          Name:
            NameFull: Kurzrock R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 03
              Text: 2022 Mar 29
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1